找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Amlodipine; Winifred G. Nayler Book 1993 Springer-Verlag Berlin Heidelberg 1993 Ca++-channel.Calcium-antagonist.PTCA.cardiovascular.hypert

[復(fù)制鏈接]
樓主: 極大
11#
發(fā)表于 2025-3-23 11:07:35 | 只看該作者
,Calcium Antagonists and the Stunned Heart — Are Vascular Selective Antagonists Protective?,onary blood flow is severe and sustained, then the inevitable outcome is that the cells in the affected area are doomed to die and necrose, irrespective of whether the tissue is subsequently reperfused (Jennings et al., 1990). Not all episodes of ischaemia are sustained and severe, however. For exam
12#
發(fā)表于 2025-3-23 16:44:42 | 只看該作者
13#
發(fā)表于 2025-3-23 21:35:31 | 只看該作者
14#
發(fā)表于 2025-3-24 00:47:10 | 只看該作者
15#
發(fā)表于 2025-3-24 04:01:22 | 只看該作者
16#
發(fā)表于 2025-3-24 09:05:00 | 只看該作者
Calcium Antagonists and Heart Failure,idity and mortality. In America, for example, one percent of the population already suffers from the complaint, and there are approximately four hundred thousand new cases presenting for treatment each year. (Sonnenblick et al., 1991). Even more disturbing is the prediction that as therapy for the m
17#
發(fā)表于 2025-3-24 13:52:27 | 只看該作者
The Side-Effects of Calcium Antagonist Therapy. Is Amlodipine Different?,ol would undoubtedly lack any appreciable side-effects. Unfortunately, and despite its obvious attraction, even the concept or a Utopian world is pure fantasy, as is the likelihood of effective therapeutic agents being developed which lack any side-effects. In reality physicians have had to cope wit
18#
發(fā)表于 2025-3-24 16:48:22 | 只看該作者
19#
發(fā)表于 2025-3-24 20:22:54 | 只看該作者
Erratum to: Die Stochastik der Iterationen, writing “Man and Superman”, because whilst it is a truism to say that . few investigators could have anticipated the recent developments which have taken place in the field of calcium antagonism. Not only was much of this progress unanticipated; at first sight it may even seem to be unreasonable. F
20#
發(fā)表于 2025-3-25 00:34:58 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-24 07:47
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
江山市| 大悟县| 都安| 吉林市| 丘北县| 龙南县| 万安县| 静乐县| 历史| 九龙城区| 拉萨市| 维西| 琼海市| 贵溪市| 昂仁县| 赣州市| 沾益县| 阜阳市| 屏东县| 铜梁县| 安平县| 雷州市| 海安县| 永仁县| 清水河县| 宾川县| 商都县| 句容市| 清远市| 霸州市| 佛山市| 南华县| 都匀市| 崇文区| 沂南县| 保靖县| 楚雄市| 奉节县| 大足县| 金华市| 依安县|